4th Annual

AML-ALL

Focus Meeting 2025

calendar icon

Marina del Rey Marriott Hotel, Santa Monica, CA

calendar icon

July 10 - 12, 2025

Last Year's Highlights

Dear Colleagues and Friends,

We are delighted to extend our warmest invitation to the AML-ALL Focus Meeting 2025, to be held at on July 10 - 12, 2025.

Centered around the theme “Updating Knowledge & Clinical Practice in 2025” this meeting provides pivotal collaboration aimed at advancing AML-ALL research and patient treatment.

This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts. Engage in riveting presentations, participate in thought-provoking debates and roundtable discussions, and connect with peers at informal social gatherings.

Chairs of AML-ALL Focus Meeting 2025:

Headshot of Chair: Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX

Headshot of Chair: Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX

Headshot of Chair: Jessica Altman, MD

Jessica Altman, MD

Northwestern University Feinberg School of Medicine, Chicago, IL

Thanks to Our Supporters

Agenda & Faculty

July 10, 2025 | Day 1

01:00 PM
Registration Opens

Session I


Moderated by:

Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
02:00 PM
CLL Highlights
Headshot of Nitin Jain, MD

Nitin Jain, MD

MD Anderson Cancer Center, Houston, TX
02:20 PM
MDS Highlights
Headshot of Rami Komrokji, MD

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL
02:40 PM
Panel Discussion
03:00 PM
Coffee Break & Networking

Session II


Moderated by:

Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
03:20 PM
BPDCN Highlights
Headshot of Naveen Pemmaraju, MD

Naveen Pemmaraju, MD

MD Anderson Cancer Center, Houston, TX
03:40 PM
Pediatric Leukemia Highlights
Headshot of David McCall, MD

David McCall, MD

MD Anderson Cancer Center, Houston, TX
04:00 PM
CML Highlights
Headshot of Hagop Kantarjian, MD

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX
04:20 PM
Panel Discussion
04:40 PM
Adjourn

July 11, 2025 | Day 2

07:45 AM
Registration Opens

Session III


Moderated by:

Headshot of Charlie Craddock, MD

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK
Headshot of Courtney DiNardo, MD

Courtney DiNardo, MD

MD Anderson Cancer Center, Houston, TX
08:30 AM
Current and Future Research Directions in AML
Headshot of Hagop Kantarjian, MD

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX
08:50 AM
The Genetic Landscape and Molecular Diagnostics in AML
Headshot of Robert Hasserjian, MD

Robert Hasserjian, MD

Massachusetts General Hospital, Boston, MA
09:10 AM
Panel Discussion
09:20 AM
Optimizing Frontline Therapy for FLT3 Mutated AML Patients Eligible for Intensive
Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
09:40 AM
Genomic Strategies to Guide the Choice of Intensive Treatment Strategies in Non-FLT3m AML
Headshot of Joshua Zeidner, MD

Joshua Zeidner, MD

UNC School of Medicine, Chapel Hill, NC
10:00 AM
Diagnostic and Molecular Work-up of Newly Diagnosed AML – The Pathologist’s Perspective
Headshot of Sanam Loghavi, MD

Sanam Loghavi, MD

MD Anderson Cancer Center, Houston, TX
10:20 AM
Panel Discussion
10:30 AM
Coffee Break & Networking

Session IV


Moderated by:

Headshot of Anjali Advani, MD

Anjali Advani, MD

Mayo Clinic, Cleveland, OH
Headshot of Jae Park, MD

Jae Park, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
10:50 AM
Molecular Biology
Headshot of Charles Mullighan, MD

Charles Mullighan, MD

St. Jude Children’s Research Hospital, Memphis, TN
11:10 AM
Philadelphia +ve ALL
Headshot of Anjali Advani, MD

Anjali Advani, MD

Mayo Clinic, Cleveland, OH
11:30 AM
Ph-ve ALL MRD
Headshot of Nicholas Short, MD

Nicholas Short, MD

MD Anderson Cancer Center, Houston, TX
11:50 AM
New Targets in ALL
Headshot of Jae Park, MD

Jae Park, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
12:10 PM
Panel Discussion
12:30 PM
Lunch Break & AML Product Theatre by Servier

Session V


Moderated by:

Headshot of Mark Levis, MD

Mark Levis, MD

MD Anderson Cancer Center, Houston, TX
Headshot of Jessica Altman, MD

Jessica Altman, MD

Northwestern University Feinberg School of Medicine, Chicago, IL
01:20 PM
Updates on the Management and Mechanisms of Resistance in R/R FLT3m AML
Headshot of Mark Levis, MD

Mark Levis, MD

MD Anderson Cancer Center, Houston, TX
01:40 PM
Emerging Strategies to Improve Outcome of Allo-transplant in AML
Headshot of Charlie Craddock, MD

Charlie Craddock, MD

Queen Elizabeth Hospital, Birmingham, UK
02:00 PM
How do I Assess for MRD in Clinical Practice and How do I Use MRD to Guide Post-remission Therapy
Headshot of Farhad Ravandi, MD

Farhad Ravandi, MD

MD Anderson Cancer Center, Houston, TX
02:20 PM
Panel Discussion
02:30 PM
How do I use IDH Inhibitors in Frontline and R/R Setting: Single Agent Versus Combinations
Headshot of Courtney DiNardo, MD

Courtney DiNardo, MD

MD Anderson Cancer Center, Houston, TX
02:50 PM
Current Status and Data with Single Agent Menin Inhibitors
Headshot of Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY
03:10 PM
Current Status and Future Directions with Menin Inhibitors in AML
Headshot of Ghayas Issa, MD

Ghayas Issa, MD

MD Anderson Cancer Center, Houston, TX
03:30 PM
Panel Discussion
03:40 PM
Coffee Break & Faculty and Fellows Photo

Session VI


Moderated by:

Headshot of Nitin Jain, MD

Nitin Jain, MD

MD Anderson Cancer Center, Houston, TX
04:00 PM
Integration of Immune-therapy into Frontline ALL
Headshot of Aaron Logan, MD

Aaron Logan, MD

UCSF Helen Diller Family Comprehensive Cancer Center, CA

Debate: Chemotherapy-free and TKI Standard of Care in Ph-positive ALL

04:20 PM
No Role for Allo
Headshot of Elias Jabbour, MD

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX
04:40 PM
Yes for Allo
Headshot of Ibrahim Aldoss, MD

Ibrahim Aldoss, MD

City of Hope Comprehensive Cancer Center, Duarte, CA
05:00 PM
AYA ALL
Headshot of Mark Litzow, MD

Mark Litzow, MD

MD Anderson Cancer Center, Houston, TX
05:20 PM
Panel Discussion
05:40 PM
Adjourn

July 12, 2025 | Day 3

08:00 AM
Registration Opens

Session VII


Moderated by:

Headshot of Joshua Zeidner, MD

Joshua Zeidner, MD

UNC School of Medicine, Chapel Hill, NC
Headshot of Tapan Kadia, MD

Tapan Kadia, MD

MD Anderson Cancer Center, Houston, TX

Debate: Upfront Triplets vs Sequential Therapies for the Treatment of AML

09:00 AM
The Case for Sequential Therapies
Headshot of Harry P. Erba, MD

Harry P. Erba, MD

Duke University, Durham, NC
09:10 AM
The Case for Upfront Triplets
Headshot of Jessica Altman, MD

Jessica Altman, MD

Northwestern University Feinberg School of Medicine, Chicago, IL
09:20 AM
Debate Discussion
09:30 AM
Developing Immune and Cellular Therapies in AML
Headshot of David Sallman, MD

David Sallman, MD

Moffitt Cancer Center, Tampa, FL
09:50 AM
Trials and Tribulations: Implementing MyeloMATCH
Headshot of Harry P. Erba, MD

Harry P. Erba, MD

Duke University, Durham, NC
10:10 AM
Panel Discussion
10:30 AM
Coffee Break & Networking

Session VIII


Moderated by:

Headshot of Jae Park, MD

Jae Park, MD

Memorial Sloan Kettering Cancer Center, New York City, NY
10:50 AM
T-Cell ALL
Headshot of Kristen O’Dwyer, MD

Kristen O’Dwyer, MD

University of Rochester, MN
11:10 AM
BCL 2 Inhibitors in ALL
Headshot of Shira Dinner, MD

Shira Dinner, MD

Northwestern Medicine, Chicago, IL
11:30 AM
PH – Like ALL
Headshot of Ibrahim Aldoss, MD

Ibrahim Aldoss, MD

City of Hope Comprehensive Cancer Center, Duarte, CA
11:50 AM
Novel Strategies: CAR-T for T-ALL and allo CAR
Headshot of Armin Ghobadi, MD

Armin Ghobadi, MD

Washington University School of Medicine, St. Louis, MO
12:10 PM
Panel Discussion
12:30 PM
Lunch Break & Networking
01:20 PM
Industry Supported Independent Expert Discussion

Session IX


Moderated by:

Headshot of Naval Daver, MD

Naval Daver, MD

MD Anderson Cancer Center, Houston, TX
Headshot of Eunice Wang, MD

Eunice Wang, MD

Roswell Park Comprehensive Cancer Center, Buffalo, NY
02:05 PM
Is HMA-VEN Based Regimen Acceptable for Fit Patients?
Headshot of Amir Fathi, MD

Amir Fathi, MD

Massachusetts General Hospital, Boston, MA
02:25 PM
Optimizing Maintenance Therapy in AML Post-consolidation and Post-transplant
Headshot of Tapan Kadia, MD

Tapan Kadia, MD

MD Anderson Cancer Center, Houston, TX
02:45 PM
Optimizing SCT Approaches Including Conditioning and Maintenance in AML
Headshot of Uday R. Popat, MD

Uday R. Popat, MD

MD Anderson Cancer Center, Houston, TX
03:05 PM
Panel Discussion
03:25 PM
Coffee Break & Networking

Session X


Moderated by:

Headshot of Aaron Logan, MD

Aaron Logan, MD

UCSF Helen Diller Family Comprehensive Cancer Center, CA
Headshot of Mark Litzow, MD

Mark Litzow, MD

MD Anderson Cancer Center, Houston, TX
03:45 PM
Is CAR-T a Bridge or a Finite Therapy in R/R B-ALL?
Headshot of Bijal Shah, MD

Bijal Shah, MD

Moffitt Cancer Center, Tampa, FL
04:05 PM
Future of ALL
Headshot of Hagop Kantarjian, MD

Hagop Kantarjian, MD

MD Anderson Cancer Center, Houston, TX
04:25 PM
Panel Discussion
04:45 PM
Adjourn

Rebecca Hill

Project Manager

How long has Rebecca Hill been in the business?

Rebecca Hill has been with MD Education since 2022

About Rebecca Hill

I am a dedicated Senior Project Manager at MD Education, specialising in coordinating global medical conferences. I have a passion for organisation and detail, and I pride myself on ensuring seamless execution of educational events. My expertise lies in orchestrating logistics and fostering collaboration among diverse teams.